Sinus Cancer disease: Malacards - Research Articles, Drugs, Genes, Clinical Trials

MCID: SNS011 MIFTS: 24	Sinus Cancer Categories: Cancer diseases, Rare diseases, Respiratory diseases	Data Licensing For inquiries, contact: [email protected]
Tissues Related diseases Publications Drugs Expand all tables

Sources

Aliases & Classifications for Sinus Cancer

MalaCards integrated aliases for Sinus Cancer:

Name: Sinus Cancer ¹⁹ ⁷⁵ ⁷¹

Classifications:

MalaCards categories:
Global: Rare diseases Cancer diseases
Anatomical: Respiratory diseases

See all MalaCards categories (disease lists)

External Ids:

UMLS ⁷¹ C3534577

Sources

Summaries for Sinus Cancer

GARD: ¹⁹ A carcinoma arising from the nasal cavity or paranasal sinuses.

MalaCards based summary: Sinus Cancer is related to paranasal sinus cancer and maxillary sinus cancer. The drugs Raspberry and Carboplatin have been mentioned in the context of this disorder. Affiliated tissues include lymph node, eye and lung.

Wikipedia: ⁷⁵ Paranasal sinuses are a group of four paired air-filled spaces that surround the nasal cavity. The... more...

Sources

Related Diseases for Sinus Cancer

Diseases in the Sinus Cancer family:

Frontal Sinus Cancer

Diseases related to Sinus Cancer via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 66)

#	Related Disease	Score
1	paranasal sinus cancer	11.4
2	maxillary sinus cancer	11.3
3	pyriform sinus cancer	11.3
4	ethmoid sinus cancer	11.3
5	frontal sinus cancer	11.2
6	paranasal sinus cancer, adult	11.2
7	sphenoidal sinus cancer	11.1
8	ethmoid sinus adenocarcinoma	11.0
9	head and neck cancer	10.2
10	adenoid cystic carcinoma	10.1
11	maxillary cancer	10.1
12	maxillary sinus squamous cell carcinoma	10.0
13	neurodegeneration with brain iron accumulation 2a	10.0
14	squamous cell carcinoma	10.0
15	adenocarcinoma	10.0
16	spastic paraplegia, intellectual disability, nystagmus, and obesity	9.9
17	papilloma	9.9
18	inverted papilloma	9.9
19	olfactory neuroblastoma	9.9
20	48,xyyy	9.9
21	abducens palsy	9.7
22	retinal detachment	9.7
23	factor vii deficiency	9.7
24	multinucleated neurons, anhydramnios, renal dysplasia, cerebellar hypoplasia, and hydranencephaly	9.7
25	rhabdomyosarcoma 2	9.7
26	stroke, ischemic	9.7
27	nasopharyngeal carcinoma	9.7
28	spastic paraplegia, ataxia, and mental retardation	9.7
29	severe cutaneous adverse reaction	9.7
30	tatton-brown-rahman syndrome	9.7
31	ptosis	9.7
32	mucositis	9.7
33	tongue carcinoma	9.7
34	dry eye syndrome	9.7
35	osteonecrosis	9.7
36	common cold	9.7
37	nasal cavity cancer	9.7
38	human papillomavirus infectious disease	9.7
39	keratomalacia	9.7
40	cauda equina syndrome	9.7
41	bronchus cancer	9.7
42	glanders	9.7
43	anodontia	9.7
44	neuroendocrine carcinoma	9.7
45	optic nerve disease	9.7
46	melanoma	9.7
47	transient cerebral ischemia	9.7
48	larynx cancer	9.7
49	laryngeal benign neoplasm	9.7
50	rhabdomyosarcoma	9.7

Graphical network of the top 20 diseases related to Sinus Cancer:

Sources

Symptoms & Phenotypes for Sinus Cancer

Sources

Drugs & Therapeutics for Sinus Cancer

Drugs for Sinus Cancer (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 34)

Name

Status

Phase

Clinical Trials

Cas Number

PubChem Id

Raspberry

Approved

Phase 1, Phase 2

Carboplatin

Approved

Phase 2

41575-94-4

10339178 38904

Fluorouracil

Approved

Phase 2

51-21-8

3385

Docetaxel

Approved, Investigational

Phase 2

114977-28-5

148124

Cisplatin

Approved

Phase 2

15663-27-1

2767 5702198 441203

Etoposide

Approved

Phase 2

33419-42-0

36462

Antimitotic Agents

Phase 2

Antimetabolites

Phase 2

Tubulin Modulators

Phase 2

Immunosuppressive Agents

Phase 2

Immunologic Factors

Phase 2

Etoposide phosphate

Phase 2

16760419

Rocuronium

Approved

119302-91-9, 143558-00-3

441290

Lidocaine

Approved, Vet_approved

137-58-6

3676

Isoflurane

Approved, Vet_approved

26675-46-7

3763

Sevoflurane

Approved, Vet_approved

28523-86-6

5206

Remifentanil

Approved

132875-61-7

60815

Fentanyl

Approved, Illicit, Investigational, Vet_approved

437-38-7

3345

Tranexamic acid

Approved

1197-18-8

5526

Succinylcholine

Approved

306-40-1, 71-27-2

5314

Propofol

Approved, Investigational, Vet_approved

2078-54-8

4943

Clove

Approved

84961-50-2

Analgesics

Antifibrinolytic Agents

Anesthetics, Intravenous

Anesthetics, Inhalation

Anesthetics, General

Anesthetics

Hypnotics and Sedatives

Analgesics, Opioid

Hemostatics

Coagulants

Narcotics

Eucalyptus

Interventional clinical trials:

#	Name	Status	NCT ID	Phase	Drugs
1	A Prospective Non-Inferiority Trial of the Use of Adaptive Radiotherapy for Head and Neck Cancer Undergoing Radiation Therapy	Completed	NCT03096808	Phase 2
2	Food-Based Modulation of Biomarkers in Human Tissues at High-Risk for Oral Cancer	Completed	NCT01469429	Phase 1, Phase 2	chemoprevention
3	Phase II Trial of Induction Therapy With Docetaxel, Cisplatin and Fluorouracil in Previously Untreated Patients With Locally Advanced Squamous Cell Carcinoma and/or Poorly Differentiated Carcinoma of the Nasal Cavity and/or Paranasal Sinuses	Recruiting	NCT00707473	Phase 2	Carboplatin;Cisplatin;Docetaxel;Fluorouracil
4	Camrelizumab Plus Chemoradiotherapy for Patients With Locoregional Cancer of Nasal Cavity and Paranasal Sinuses: a Phase II Multicenter Study	Recruiting	NCT05114707	Phase 2	camrelizumab
5	A Phase II, Single-Arm Trial Assessing Local Control of Near Total Endoscopic Resection Followed by Concurrent Chemotherapy and Proton Radiation in the Treatment of Unresectable Sinonasal Tumors	Active, not recruiting	NCT03274414	Phase 2	Cisplatin;cisplatin and etoposide
6	Integrated Cancer Repository for Cancer Research	Recruiting	NCT02012699
7	Prospective Observational Single Arm Study of Endoscopic Surgery in the Treatment of Soft Tissue Sarcoma in Nasal and Paranasal Sinus	Recruiting	NCT05614375
8	The Observational Clinical Registry of the European Reference Network on Rare Adult Solid Cancers: the Protocol for the Rare Head and Neck Cancers	Recruiting	NCT05483374
9	Comparison of Inhalational Anesthesia With Intravenous Tranexamic Acid and Total Intravenous Anesthesia on Surgical Field Quality in Endoscopic Sinus Surgery	Not yet recruiting	NCT05639686		Tranexamic acid injection;Total Intravenous Anesthesia;Inhalational isoflurane
10	Olfactory Training For Post Radiation Olfactory Loss In Patients With Paranasal Sinus and Nasopharyngeal Carcinoma	Terminated	NCT03049358

Search NIH Clinical Center for Sinus Cancer

Sources

Genetic Tests for Sinus Cancer

Sources

Anatomical Context for Sinus Cancer

Organs/tissues related to Sinus Cancer:

MalaCards : Lymph Node, Eye, Lung, Bone, Neutrophil

Sources

Publications for Sinus Cancer

Articles related to Sinus Cancer:

(show top 50) (show all 313)

#	Title	Authors	PMID	Year
1	Treatment of electroplating industry wastewater: a review on the various techniques. ⁶²	Rajoria S...Sangal VK	35084684	2022
2	Outcomes of Patients Undergoing Emergency Tracheostomy During COVID 19 Pandemic: Our Experience from a Tertiary Care Centre in North-East India. ⁶²	Khanna S...Dey R	33686367	2022
3	Lymph node ratio predicts recurrence-free survival and disease-specific survival of patients with pyriform sinus squamous cell carcinoma. ⁶²	Liu Y...Liu S	36184282	2022
4	Relationship between Chronic Rhinosinusitis and the Incidence of Head and Neck Cancer: A National Population-Based Study. ⁶²	Han KD...Lee KI	36142963	2022
5	Photoimmunotherapy with surgical navigation and computed tomography guidance for recurrent maxillary sinus carcinoma. ⁶²	Koyama S...Fujiwara K	36123249	2022
6	Associations of Body Mass Index and Waist Circumference with the Risk of Head and Neck Cancer: A National Population-Based Study. ⁶²	Kim CS...Joo YH	36010881	2022
7	Organ preservation surgery for pyriform sinus carcinoma with vocal cord fixation: functional and oncological outcomes. ⁶²	Xu S...Liu J	34825265	2022
8	Palatal mucoperiosteal flap for oro-nasal fistula following maxillectomy for maxillary sinus cancer. ⁶²	Honda K...Miura M	35778286	2022
9	Impact of Socioeconomic Status on Paranasal Sinus Cancer Disease-Specific and Conditional Survival. ⁶²	Sharma RK...Gudis DA	34281443	2022
10	Regression of advanced maxillary sinus cancer with orbital invasion by combined chemotherapy and immunotherapy: A one-year follow-up case report. ⁶²	Kuo YH...Lin CS	35350406	2022
11	A case of maxillary cancer treated by intra-arterial therapy using a steerable microcatheter. ⁶²	Yamanishi T...Yamagami T	33412974	2022
12	Organized Hematoma after Intra-Arterial Chemoradiotherapy for Maxillary Sinus Cancer: A Case Report. ⁶²	Tanida M...Inohara H	35392701	2022
13	Salvage surgery improves the treatment outcome of patients with residual/recurrent maxillary sinus cancer after superselective intra-arterial cisplatin infusion with concomitant radiation therapy. ⁶²	Tsushima N...Homma A	33866400	2022
14	Free double-paddle superficial circumflex iliac perforator flap transfer for partial maxillectomy reconstruction: A case report. ⁶²	Yamamoto T...Ishiura R	34617610	2022
15	A domain knowledge enhanced yield based deep learning classifier identifies perineural invasion in oral cavity squamous cell carcinoma. ⁶²	Lee LY...Liao CT	36353548	2022
16	Case report: 18F-FDG PET confirmed pupil-sparing third nerve palsy heralding aseptic cavernous sinus embolism in patient with chest malignancy. ⁶²	Xiong J...Cui F	36117807	2022
17	A long-term survival case with proton beam therapy for advanced sphenoid sinus cancer with hypopituitarism. ⁶²	Ishikawa Y...Murakami M	35116220	2022
18	Occupational exposure to hexavalent chromium. Part II. Hazard assessment of carcinogenic effects. ⁶²	den Braver-Sewradj SP...Hessel EVS	34506880	2021
19	Racial and ethnic disparities in paranasal sinus malignancies. ⁶²	Sharma RK...Gudis DA	34096200	2021
20	Radiologic criteria of retropharyngeal lymph node metastasis in maxillary sinus cancer. ⁶²	Kosugi Y...Sasai K	34565434	2021
21	Imaging predictor of ophthalmic involvement in maxillary sinus cancer during super selective intra-arterial cisplatin infusion and concomitant radiotherapy (RADPLAT). ⁶²	Ashida H...Ojiri H	34399796	2021
22	The incidence of myocardial infarction and stroke in head and neck cancer patients. ⁶²	Kwon HK...Lee BJ	33603026	2021
23	A Systematic Review of Proton Therapy for the Management of Nasopharyngeal Cancer. ⁶²	Lee A...Lee NY	34285941	2021
24	Invasion of the pterygoid plates: an indicator for regional lymph node failure in maxillary sinus cancer. ⁶²	Kosugi Y...Sasai K	33407616	2021
25	Pathological evaluation of radiotherapy and concomitant intraarterial cisplatin for maxillary sinus cancer. ⁶²	Makino T...Nishizaki K	32359864	2020
26	Treatment Outcome and Patterns of Failure in Patients with Maxillary Sinus Cancer: Clinical Experience from a Regional Cancer Centre in North India. ⁶²	Bhasker S...Mohanti BK	33013118	2020
27	["Point line anterograde dissection" for the safe preparation of supraclavicular flap]. ⁶²	Zhou J...Cao L	32911887	2020
28	Malignant tumors of the maxillary sinus: Prognostic impact of neurovascular invasion in a series of 138 patients. ⁶²	Ferrari M...Nicolai P	32298995	2020
29	PI3K/AKT/mTOR pathway and autophagy regulator genes in paranasal squamous cell carcinoma metastasis. ⁶²	Biray Avci C...Gode S	32319010	2020
30	A rare case of cerebral hemorrhage associated with intra-arterial infusion chemotherapy for advanced sphenoid sinus cancer. ⁶²	Heianna J...Murayama S	32719293	2020
31	Establishment and characterization of patient-derived xenografts as paraclinical models for head and neck cancer. ⁶²	Kang HN...Kim HR	32293356	2020
32	[Reconstruction of orbital floor defect with preserved orbital contents after advanced maxillary sinus cancer resection]. ⁶²	Hu HY...Shi GG	31954385	2020
33	Metabolism and Functions of Amino Acids in Sense Organs. ⁶²	Wu G	32761578	2020
34	Dose distribution of intensity-modulated proton therapy with and without a multi-leaf collimator for the treatment of maxillary sinus cancer: a comparative effectiveness study. ⁶²	Sugiyama S...Kanazawa S	31752928	2019
35	Sinonasal Undifferentiated Carcinoma in a Patient Previously Treated for an Intestinal-Type Adenocarcinoma: Metachronous Neoplasms or Recurrence of a Different Tumor Type? ⁶²	Valentini V...Tombolini V	31763244	2019
36	Therapeutic efficacy of regional and systemic chemotherapy in advanced maxillary sinus cancer. ⁶²	Yi KI...Cho KS	30924582	2019
37	Definitive Radiation Therapy Versus Postoperative Radiation Therapy for Patients With Maxillary Sinus Cancer Invading the Upper Jaw. ⁶²	Wang F...Zhang C	30882578	2019
38	Salvage surgery for a locally persistent or recurrent tumour in maxillary cancer patients who have undergone radiotherapy and concomitant intra-arterial cisplatin: implications for surgical margin assessment. ⁶²	Ono T...Umeno H	30447876	2019
39	Survival Outcomes for Induction vs Adjuvant Chemotherapy in Squamous Cell Carcinoma of the Maxillary Sinus. ⁶²	Kuo P...Judson BL	30296902	2019
40	Analysis of expression of p63 and caspase-3 and their predictive value in patients with squamous cell carcinoma of maxillary sinus. ⁶²	Kovtunenko OV...Shponka IS	32124745	2019
41	Oncological and functional outcomes of trans-oral robotic surgery for pyriform sinus carcinoma: A French GETTEC group study. ⁶²	Mazerolle P...Vergez S	30409296	2018
42	The Synergistic Effect of Immune Checkpoint Blockade and Radiotherapy in Recurrent/Metastatic Sinonasal Cancer. ⁶²	Yazici G...Ozyigit G	30648054	2018
43	Combined transoral-transhyoid endoscopic approach for hypopharyngeal cancer. ⁶²	Honda K...Kimura T	29402609	2018
44	Dose-finding and efficacy confirmation trial of the superselective intra-arterial infusion of cisplatin and concomitant radiotherapy for locally advanced maxillary sinus cancer (Japan Clinical Oncology Group 1212): Dose-finding phase. ⁶²	Homma A...Hayashi R	29130565	2018
45	Review of carcinogenicity of hexavalent chrome and proposal of revising approval standards for an occupational cancers in Korea. ⁶²	Kim J...Kim DH	29423230	2018
46	Options of medical treatment and laryngeal function preservation in elderly patients with medial wall pyriform sinus cancer. ⁶²	Wang Q...Zhang M	30464497	2018
47	[Surgical management of elderly patients with medial wall pyriform sinus cancer]. ⁶²	Wang Q...Zhao Y	29262511	2017
48	Results of preoperative chemoradiotherapy for patients with advanced cancer of the nasal cavity and paranasal sinuses. ⁶²	Fernstrom E...Bjork-Eriksson T	28749194	2017
49	Recurrent maxillary sinus cancer with only adrenal metastasis. ⁶²	Chang HJ...Lee HY	29181177	2017
50	Managing head and neck malignancy arising in a field of Crohn disease inflammation: Report of a case. ⁶²	Yver C...Basu D	29121377	2017